Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AssayPro is a privately held U.S.-based biotechnology and research tools company that develops and manufactures immunological assay kits and reagents for academic, pharmaceutical, and biotechnology researchers. Its commercial portfolio includes AssayMax ELISA kits, AssaySense chromogenic activity kits, AssayLite fluorescent multiplex kits, antibodies, proteins, plasma and serum products, controls, and related reagents. The company also offers custom services such as antibody development, protein expression and purification, and conjugation support. AssayPro appears to operate as a commercial life science tools supplier rather than a therapeutic drug developer, with its business centered on assay products for research and analytical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AssayPro.